Mesoblast (MESO) Revenue (2016 - 2023)

Mesoblast has disclosed Revenue across 8 years of filings, most recently posting -$5.4 million for Q2 2023.

• Revenue for Q2 2023 came in at -$5.4 million, down 257.89% year-over-year; the trailing twelve-month figure through Mar 2023 was $8.8 million (down 0.6% YoY), and the FY2025 annual result was $17.2 million, changed N/A from the prior year.
• Revenue came in at -$5.4 million for Q2 2023 at Mesoblast, down from $1.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $26.2 million in Q2 2020 to a low of -$5.4 million in Q2 2023.
• The 5-year median for Revenue is $2.0 million (2019), against an average of $2.9 million.
• Across the five-year window, Revenue surged 1233.71% in 2020 and tumbled 257.89% in 2023, its largest moves.
• Mesoblast's Revenue stood at $2.0 million in 2019, then gained by 13.81% to $2.2 million in 2020, then gained by 6.29% to $2.4 million in 2021, then fell by 16.88% to $2.0 million in 2022, then sank by 370.81% to -$5.4 million in 2023.
• The last three Revenue figures came in at -$5.4 million (Q2 2023), $1.9 million (Q1 2023), and $2.0 million (Q4 2022), per Business Quant data.